Narrow search
Showing 1 - 10 of 1,961
Cover Image
The effect of FDA advisories on branded pharmaceutical firms' valuations and promotion efforts
Conti, Rena M.; Huskamp, Haiden A.; Berndt, Ernst R. - 2011
"The NBER Bulletin on Aging and Health provides summaries of publications like this. You can sign up to receive the NBER Bulletin on Aging and Health by email. The US Food and Drug Administration (FDA) expends considerable efforts in regulating medications approved for use. Yet the impact of...
Persistent link: https://www.econbiz.de/10009374023
Cover Image
European pharmaceutical price regulation, firm profitability, and R&D spending
Golec, Joseph; Vernon, John A. - 2006
Persistent link: https://www.econbiz.de/10003392874
Cover Image
Technology diffusion and productivity growth in health care
Skinner, Jonathan; Staiger, Douglas - 2009
Persistent link: https://www.econbiz.de/10003829599
Cover Image
The geography of prescription pharmaceuticals supplied to the U.S. : levels, trends and implications
Kaygisiz, Neriman Beste; Shivdasani, Yashna; Conti, Rena M. - 2019
Persistent link: https://www.econbiz.de/10012171005
Cover Image
Using audit studies to test for physician induced demand : the case of antibiotic abuse in China
Currie, Janet M.; Lin, Wanchuan; Meng, Juanjuan - 2012
Persistent link: https://www.econbiz.de/10009560782
Cover Image
Developing novel drugs
Krieger, Joshua L.; Li, Danielle; Papanikolaou, Dimitris - 2018
Persistent link: https://www.econbiz.de/10011875971
Cover Image
Generics and new goods in pharmaceutical price indexes
Griliches, Zvi; Cockburn, Iain - 1993
Persistent link: https://www.econbiz.de/10000857446
Cover Image
Generic entry and the pricing of pharmaceuticals
Frank, Richard G.; Salkever, David S. - 1995
Persistent link: https://www.econbiz.de/10000922612
Cover Image
The introduction of pharmaceutical product patents in India : "heartless exploitation of the poor and suffering"?
Lanjouw, Jean Olson - 1998
Persistent link: https://www.econbiz.de/10000654419
Cover Image
Patient welfare and patient compliance : an empirical framework for measuring the benefits from pharmaceutical innovation
Ellickson, Paul; Stern, Scott; Trajtenberg, Manuel - 1999
Persistent link: https://www.econbiz.de/10001355791